AGP Executive Report
Last update: 2 hours agoDEA Rescheduling Hearing: The federal government kicked off marijuana rescheduling arguments, pitching cannabis as having accepted medical value and lower abuse/overdose risk than opioids and alcohol, with the process running through mid-July. CBD Consumer Watch: CBDWatchlist.com launched a 2026 CBD Gummies and CBD Oil Transparency Review Initiative to help shoppers compare labeling, lab tests, and refund/shipping terms. Jail Safety Probe: A South Carolina sheriff says detention-center cases were withheld, including a death linked to synthetic cannabinoids (K2/Spice), leading to the arrest of the compliance director. Hemp Product Pushback: A restaurant association urged Congress to rethink a forthcoming hemp-products approach, asking for a delay. Gun Policy Spillover: The U.S. Supreme Court agreed to hear challenges to assault-style rifle bans, while also turning away a separate firearms age-restriction case—showing how major court fights keep reshaping drug-adjacent policy debates. Local CBD/Weed Enforcement: Police reports across the week included marijuana-linked arrests and seizures, from traffic stops to suspected supply cases.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.